Technology commercialized

DIASTEP - an off the shelf footwear for low risk diabetics

Brief description of Technology

  • Diabetes is a very serious chronic disease
  • India is the Diabetes Capital of the World with over 60 million affected by it
  • Foot is one of the major organs affected
  • Estimated that over 50% of lower extremity amputations are linked to diabetes
  • Healthcare costs and loss of productivity associated with diabetic foot complications are enormous

CSIR-CLRI developed ‘special footwear-DIASTEP’

  • Goes a long way to help reduce diabetic foot complications
  • Ensures a better quality of life with enhanced productivity for these patients

DIASTEP: a therapeutic open footwear for the diabetic patients with risk of foot problems

  • reduces the abnormal distribution of plantar foot pressure
  • provides the patients with diabetic foot risk, complete open footwear
  • comprising selective topsole, insole and bottom sole made of appropriately selected material.

Footwear features

  • Cow softy leather upper
  • Unit moulded sole made from Polyurethane (PU) with extra depth to provide larger area for more effective pressure distribution
  • outsole having special tread for better grip and traction.
  • Extensive patient trials have established the efficacy of the footwear.

Click here for contact details of the licencee 

For Further Information Please Contact

Head, SPDC Division
CLRI, Adyar, Chennai 600 020
Tel.: +91-44-24437218
Email: spdc@clri.res.in